GE Healthcare    Privacy Policy     Terms of Use     Contact Us    © 2015 Copyright General Electric Company


Invenia ABUS – Look differently at dense breast tissue.

  • GE Healthcare is the sole manufacturer of FDA-approved Automated Breast Ultrasound designed for the screening environment
  • InveniaTM ABUS helps find cancers hidden in dense tissue and unseen by mammography
  • Invenia ABUS helps find up to 55% more invasive cancer* over mammography alone1
  • Gain confidence that your patients with dense breasts have been imaged thoroughly
Find an ABUS Facility

Learn more about Automated Breast Ultrasound

What can be done for patients with dense breasts?

Find out how some radiologists are screening patients with dense breasts and the results they have experienced

Carole's Story

Meet Carole. The Invenia ABUS gives her and her family piece of mind that she is being screened thoroughly and according to her risk factors.

Joyce's Story

Meet Joyce, a cancer survivor who credits her early cancer detection to the Invenia ABUS exam and to the doctor who screened her with Invenia ABUS.

White Dot

Can you see white on white? Cancer can hide in dense breasts, Invenia ABUS supplemental screening helps physicians find hidden cancer.

Download Assessing Improvement in Detection of Breast Cancer with Three-dimensional Automated Breast US in Women with Dense Breast Tissue: The SomoInsight Study,which shows how ABUS technology can help increase invasive cancer detection by 55%* over mammography alone1

Download an ABUS exam patient pamphlet

Learn more about Invenia ABUS




Invenia ABUS Acquisition Demonstration

Watch how Invenia ABUS acquires images.

Invenia ABUS patient exam video

Watch an Invenia ABUS patient exam demonstration.

Learn about Invenia ABUS

* Increase in sensitivity was associated with a decrease in overall specificity.
1. 55% increase in invasive cancer detection: Brem RF, Tabár L, et.al. Assessing Improvement in Detection of Breast Cancer with Three-dimensional Automated Breast US in Women with Dense Breast Tissue: The SomoInsight Study. Radiology. 2015 Mar; 274(3): 663-73.
2. Mammography may miss over one third of cancers in dense breasts. Mandelson et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000; 92:1081–1087.
3. Over 40% of women in the United States have dense breast tissue: Pisano et al. Diagnostic Performance of Digital versus Film Mammography for Breast Cancer Screening. NEJM 2005;353:1773
4. Having dense breasts increases the likelihood of a woman developing cancer by 4-6 times. Boyd, N.F. et.al. Mammographic Density and the Risk and Detection of Breast Cancer, N Engl J Med 2007;356:227-36.

Brief Statement
 The Invenia ABUS is indicated as an adjunct to mammography or breast cancer screening in asymptomatic women for whom screening mammography findings are normal or benign (BI-RADS® Assessment Category 1 or 2), with dense breast parenchyma (BI-RADS Composition/Density C or D), and have not had previous clinical breast intervention. The device is intended to increase breast cancer detection in the described patient population. The Invenia ABUS may also be used for diagnostic ultrasound imaging of the breast in symptomatic women. Prescription device. See the device manual for detailed information, contraindications, warnings, precautions, potential adverse events.